Le Lézard
Classified in: Health
Subjects: PDT, IMA

MedSafety Solutions Earns EU-MDR Certification


CENTENNIAL, Colo., Oct. 25, 2021 /PRNewswire/ -- MedSafety Solutions today announced that it has received the European Union Medical Devices Regulations (EU-MDR) certification as of September 9, 2021. This achievement is a major milestone for MedSafety Solutions in its ongoing mission to provide hospital pharmacies in the European market with the products and expertise they need to perform safely and effectively.

The British Standards Institution BSI completed their conformity assessment to include quality management systems as well as general safety and performance standards. As a result of this assessment, conducted by audit and technical review, BSI determined that MedSafety Solutions met the needed requirements and issued its EU Quality Management System Certificate.

"Receiving this certification demonstrates our commitment to compliance with new regulations and to meeting customers' needs safely and predictably," says Steve van Engen, founder and CEO at MedSafety Solutions. "Additionally, receiving this certification ahead of many other companies will serve as a distinct competitive advantage."

This news takes on significant importance in that the new certification:

To learn more about the EU-MDR certification, click here to contact us.

About MedSafety Solutions: MedSafety Solutions provides best-of-class IV Preparation and Oral Administration products that support the safe and efficient operation of hospital pharmacies. In response to the urgency around the timely distribution and delivery of hospital pharmacy equipment and supplies, MedSafety's comprehensive, world-wide distribution network was developed to assure the punctual, dependable fulfillment of its customer's needs.

More information about MedSafety Solutions and its products can be found on the company's website, www.medsafetysolutions.com.

Media Contact:
MedSafety Solutions
[email protected] 
720.500.2500

SOURCE MedSafety Solutions


These press releases may also interest you

at 10:45
eBlu Solutions, a leading provider of innovative technology solutions for the specialty healthcare industry, is pleased to announce the addition of Doug Lawrence to the Executive Leadership team in the role of Chief Revenue Officer. "We're not just...

at 09:18
NUVISTA Mental Health proudly announces its participation as a Gold Sponsor for the 2024 Ontario First...

at 09:05
Cardurion Pharmaceuticals, Inc. ("Cardurion"), a clinical-stage biotechnology company developing next-generation therapeutics for the treatment of cardiovascular diseases, today announced the presentation of positive clinical data from CARDINAL?HF,...

at 06:05
Dr. Majid Al Fayyadh, CEO of King Faisal Specialist Hospital and Research Centre (KFSH&RC) joined the Gulf Creatives Conference (GCC) at Harvard 2024. The event, GCC at Harvard, is organized by The Diwan, an organization run by graduate students at...

at 06:00
Replicate Bioscience, a clinical-stage company pioneering novel self-replicating RNA (srRNA) technology for use across a range of infectious disease, oncology,...

at 03:14
Caliway Biopharmaceuticals (Caliway) is pleased to announce its participation to share the latest clinical advancements at the upcoming 2024 BIO International Convention on Wednesday, June 5th, at 11:45 a.m. PDT. The presentation will take place in...



News published on and distributed by: